Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

Completed · Phase 2

Conditions studied: Non-small Cell Lung Cancer

In brief

Determine whether patients have a decreased incidence of grade 3 and grade 4 neutropenia when Filgrastim-SD/01 is given with docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.

Key facts

Study ID

NCT00050674

Run by

Schwartzberg, Lee, M.D.

People needed

40

Starts

2001-11-01

Expected to finish

2007-02-01

Last updated by the study team

2012-12-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• The West Clinic, PC — Southaven, Mississippi, United States
• The West Clinic, PC — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.